Breaking News Instant updates and real-time market news.

PFE

Pfizer

$33.77

0.205 (0.61%)

11:20
10/10/16
10/10
11:20
10/10/16
11:20

Big prints in Pfizer puts and calls

Big prints in Pfizer puts and calls. 30K Jan 37 calls sold at 14c to buy 13.7K Jan 28 puts for 19c. Open interest is sufficient to cover, but the stock is roughy midway between the two strikes and so the risk-reversal is probably a new position. If so, the defensive play is being opened ahead of earnings on 11/1.

  • 01

    Nov

PFE Pfizer
$33.77

0.205 (0.61%)

08/23/16
PIPR
08/23/16
NO CHANGE
PIPR
Pfizer acquisition 'a good fit strategically,' says Piper Jaffray
After Pfizer (PFE) agreed to buy Medivation (MDVN), Piper Jaffray analyst Richard Purkiss says that Pfizer has obtained Xtandi, "a blockbuster prostate cancer treatment," and "a close-to-market and late-stage pipeline." The analyst thinks that Xtandi's expansion to use in adjuvant prostate cancer could increase its sales by 65%-70%. He keeps a $54 price target and Overweight rating on Pfizer.
08/23/16
RHCO
08/23/16
DOWNGRADE
RHCO
Neutral
Medivation downgraded to Neutral from Buy at SunTrust
Medivation (MDVN) has agreed to be acquired by Pfizer (PFE) for $81.50 per share.
09/14/16
BMOC
09/14/16
NO CHANGE
BMOC
Pfizer should exceed fiscal 2016 guidance, says BMO Capital
BMO Capital analyst Alex Arfaei says that Pfizer should exceed its fiscal 2016 guidance. The analyst says that Medivation, which Pfizer agreed to acquire, gives Pfizer another growth driver. Additionally, Pfizer has a number of other "high margin specialty drugs," according to the analyst. He says that the stock's dividend yield is "attractive," and he keeps a $40 price target and Outperform rating on the shares.
10/07/16
ROTH
10/07/16
NO CHANGE
Target $160
ROTH
Buy
ICU Medical price target raised to $160 from $132 at Roth Capital
Roth Capital analyst Chris Lewis raised his price target for ICU Medical (ICUI) to $160 from $132 after the company announced an agreement to acquire Hospira Infusion Systems from Pfizer (PFE) for $1B. The analyst is overall positive on the deal as it removes the long-standing customer concentration overhang and grows ICU Medical into a legitimate pure-play infusion therapy company with a complete product portfolio. The company also preannounced Q3 preliminary results above expectations, he notes. Lewis reiterates a Buy rating on ICU Medical's shares.

TODAY'S FREE FLY STORIES

LYB

LyondellBasell

$102.16

-1.3 (-1.26%)

05:01
09/19/18
09/19
05:01
09/19/18
05:01
Downgrade
LyondellBasell rating change  »

LyondellBasell downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSEZY

SSE

$0.00

(0.00%)

04:57
09/19/18
09/19
04:57
09/19/18
04:57
Upgrade
SSE rating change  »

SSE upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALLK

Allakos

$44.88

0.95 (2.16%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
RBC Capital hardware analyst to hold a group luncheon »

Hardware & Semis…

WCN

Waste Connections

$80.19

0.745 (0.94%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Waste Connections participates in a conference call with UBS »

Analyst Windham holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Breaking General news story  »

Week of 9/14 EIA…

HHC

Howard Hughes

$124.65

-0.88 (-0.70%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Howard Hughes management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

BAESY

BAE Systems

$0.00

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
BAE Systems management to meet with Morgan Stanley »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Housing Starts to be reported at 08:30 »

August Housing Starts…

AMSF

Amerisafe

$63.80

-0.35 (-0.55%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Amerisafe management to meet with SunTrust »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

AKTS

Akoustis

$8.08

0.04 (0.50%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Akoustis management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

ATTO

Atento

$7.60

-0.1 (-1.30%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Atento management to meet with Barrington »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

GCI

Gannett

$9.92

0.135 (1.38%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Gannett management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

NHI

National Health Investors

$76.47

-1.07 (-1.38%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
National Health Investors management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

RWT

Redwood Trust

$16.42

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Redwood Trust management to meet with Compass Point »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

NEE

NextEra Energy

$173.44

-0.41 (-0.24%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
NextEra Energy management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 11

    Nov

NICE

Nice Systems

$115.64

-0.61 (-0.52%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Nice Systems management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Breaking General news story  »

Week of 9/14 MBA Mortgage…

04:55
09/19/18
09/19
04:55
09/19/18
04:55
General news
Housing Starts Permits to be reported at 08:30 »

August Housing Starts…

ESE

Esco Technologies

$67.00

-0.1 (-0.15%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Esco Technologies management to meet with B. Riley FBR »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 06

    Nov

GNBC

Green Bancorp

$23.10

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Green Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

NP

Neenah Paper

$94.65

-1.35 (-1.41%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Neenah Paper management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 24

    Sep

VCTR

Victory Capital

$9.23

-0.25 (-2.64%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Victory Capital management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

VSM

Versum Materials

$35.65

-0.305 (-0.85%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Versum Materials management to meet with Jefferies »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CHKP

Check Point

$119.67

(0.00%)

04:55
09/19/18
09/19
04:55
09/19/18
04:55
Conference/Events
Check Point management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

  • 21

    Sep

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 06

    Dec

  • 10

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.